Adjuvant therapy for gastric cancer: revisiting the past to clarify the future.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis.World journal of surgical oncology · 2016
   Pooled it
2. Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.PloS one · 2013
   Pooled it
3. Perioperative immunotherapy in gastric cancer in the spotlight.World journal of clinical oncology · 2025
   Review
4. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.BMC cancer · 2021
   Article
5. Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer.Frontiers in oncology · 2020
   Article
6. Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.The oncologist · 2016
   Review
7. The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.World journal of surgical oncology · 2016
   Article
8. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.World journal of gastroenterology · 2015
   Article
9. Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.Journal of hematology & oncology · 2013
   Review
10. Indirect comparison showed survival benefit from adjuvant chemoradiotherapy in completely resected gastric cancer with d2 lymphadenectomy.Gastroenterology research and practice · 2013
    Review
11. Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.Radiation oncology (London, England) · 2012
    Review

Corrections and comments

• Comment on
  Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.2012

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as